Skip to main content

Advertisement

Log in

Mechanisms of IgE Inflammation

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

The prevalence of diseases such as allergic asthma and rhinitis continues to increase in the United States, affecting millions of people. It is well-established that allergy contributes to the pathogenesis of most asthma, especially in children and young adults. Despite current therapy (eg, inhaled corticosteroids, anti-leukotrienes, and bronchodilators), patients with moderate to severe asthma remain symptomatic and experience frequent exacerbations of disease requiring oral corticosteroids, emergency department treatments, and hospitalizations. Allergic diseases are traditionally referred to as immediate or type 1 hypersensitivity reactions, with IgE as a critical factor. IgE is involved in allergic inflammation, especially in early-phase response, but it may also be involved in the late-phase allergic response. A direct correlation between serum IgE levels and asthma exists. As logarithm IgE values increase, asthma prevalence increases linearly, even in patients who are categorized as having nonallergic asthma. In addition, there is a significant, although low association in allergic rhinitis with IgE levels and positive skin test reactivity to pollens. Recent advances in our understanding of the role of IgE in allergic inflammation have led to the development of a monoclonal antibody to IgE that reduces IgE levels, thereby reducing allergic inflammation. This review aims to provide an overview of the basic science of the IgE molecule and the clinical efficacy of anti-IgE therapy in allergic and asthmatic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ishizaka K, Ishizaka T. Identification of gamma E-antibodies as a carrier of reaginic activity. J Immunol. 1967;99:1187–98.

    PubMed  CAS  Google Scholar 

  2. Beasley R, Crane J, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol. 2000;105(suppl):S-466–72.

    CAS  Google Scholar 

  3. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with scrum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989;230:271–7.

    Article  Google Scholar 

  4. Sunyer J, Anto JM, Sabria J, et al. Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol. 1995;95:699–706.

    Article  PubMed  CAS  Google Scholar 

  5. Garman SC, Wurzburg BA, Trachevskaya SS, Kinet JP, Jardetzky TS. Structure of the FC fragment of human IgE bound to its high-affinity receptor FcepsilonRI alpha. Nature. 2000;406:259–66.

    Article  PubMed  CAS  Google Scholar 

  6. Sutton BJ, Gould HJ. The human IgE network. Nature. 1993;366:421–8.

    Article  PubMed  CAS  Google Scholar 

  7. Vercelli D, Helm B, Marsh P, et al. The B-cell binding site on human immunoglobulin E. Nature. 1989;338:649–51.

    Article  PubMed  CAS  Google Scholar 

  8. Nissim A, Schwarzbaum S, Siraganian R, Eshhar Z. Fine specificity of the IgE interaction with the low and high affinity Fc receptor. J Immunol. 1993;150:1365–74.

    PubMed  CAS  Google Scholar 

  9. Presta L, Shields R, O’Connell L, et al. The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 1994;269:26368–73.

    Google Scholar 

  10. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol. 2003;3:721–32.

    Article  PubMed  CAS  Google Scholar 

  11. Basu M, Hakimi J, Dharm E, Kondas JA, Tsien WH, et al. Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J Biol Chem. 1993;268:13118–27.

    PubMed  CAS  Google Scholar 

  12. Keown MB, Ghirlando R, Young RJ, et al. Hydrodynamic studies of a complex between the Fc fragment of human IgE and soluble fragment of the Fc epsilon RI alpha chain. Proc Natl Acad Sci USA. 1995;92:1841–5.

    Article  PubMed  CAS  Google Scholar 

  13. Keown MB, Ghirlando R, Mackay GA, Sutton BJ, Gould HJ. Basis of the 1:1 stoichiometry of the high-affinity IgE receptor Fc epsilon RI-IgE complex. Eur Biophys J. 1997;25:471–6.

    Article  PubMed  CAS  Google Scholar 

  14. Turner K, Kinet JP. Signaling though the high-affinity IgE receptor Fc epsilonRI. Nature. 1999;402(supp):B23–30.

    Article  Google Scholar 

  15. Chaudhuri J, Tian M, Khoung C, et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 2003;422:726–30.

    Article  PubMed  CAS  Google Scholar 

  16. Jabara HH, Ahern DJ, Verceilli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Immunol. 1991;147:1557–60.

    PubMed  CAS  Google Scholar 

  17. Jabara HH, Brodeur SR, Geha RS. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest. 2001;107:371–8.

    Article  PubMed  CAS  Google Scholar 

  18. Litinskiy MB, Nardelli B, Hilbert DM, et al. DCs induce DC40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3:822–9.

    Article  PubMed  CAS  Google Scholar 

  19. Brodeur SR, Angelini F, Bacharier LB, et al. C4b-binding protein (C4BP) activates B cells through CD40 receptor. Immunity. 2003;18:837–48.

    Article  PubMed  CAS  Google Scholar 

  20. Gounni AS, Lamkhioued B, Delaporte E, et al. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J Allergy Clin Immunol. 1994;94:1214–6.

    Article  PubMed  CAS  Google Scholar 

  21. Maurer D, Ebner C, Reninger B, Fiebiger F, et al. The high-affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 1995;154:6285–90.

    PubMed  CAS  Google Scholar 

  22. Novak N, Kraft S, Bieber T. Unraveling the mission of FcepsilonRI on antigen-presenting cells. J Allergy Clin Immunol. 2003;111-:38–44.

    Article  PubMed  Google Scholar 

  23. Robertson MW. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor alpha-subunit ectodomain. Domain localization of the IgE-binding site. J Biol Chem. 1993;268:12736–43.

    PubMed  CAS  Google Scholar 

  24. Garman SC, Kinet JP, Jardetzky TS. Crystal structure of the human high-affinity IgE receptor. Cell. 1998;95:951–61.

    Article  PubMed  CAS  Google Scholar 

  25. Keown MB, Henry AJ, Ghirlando R, Sutton BJ, Gould HJ. Thermodynamics of the interaction of human immunoglobulin E with its high-affinity receptor Fc epsilon RI. Biochemistry. 1998;37:8863–9.

    Article  PubMed  CAS  Google Scholar 

  26. Metzger H. The receptor with high affinity for IgE. Immunol Rev. 1992;125:37–48.

    Article  PubMed  CAS  Google Scholar 

  27. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol. 1999;17:931–72.

    Article  PubMed  CAS  Google Scholar 

  28. Letourner O, Schi S, Wilette-Brown, Robertson MW, Kinet JP. Glycosylation of human truncated Fc epsilon RI alpha chain is necessary for efficient folding in the endoplasmic reticulum. J Biol Chem. 1995;270:8249–56.

    Article  Google Scholar 

  29. Saini SS, MacGlashan d. How IgE upregulates the allergic response. Curr Opin Immunol. 2002;14:694–7.

    Article  PubMed  CAS  Google Scholar 

  30. Novak N, Bieber T, Katoh N. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol. 2001;167:797–804.

    PubMed  CAS  Google Scholar 

  31. Kraft S, Katoh N, Novak N, Koch S, Bieber T. Unexpected functions of FcepsilonRI on antigen-presenting cells. Int Arch Allergy Immunol. 2001;124:35–7.

    Article  PubMed  CAS  Google Scholar 

  32. MacGlashan Jr DW, Bochner BS, Adelman DC, Jardieu PM, Togias A, Lichtenstein LM. Serum IgE level drives basophil and mast cells IgE receptor display. Int Arch Allergy Immunol. 1997;113:45–7.

    Article  PubMed  CAS  Google Scholar 

  33. MacGlashan Jr DW, Bochner BS, Adelman DC, et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti IgE antibody. J Immunol. 1994;158:1438–45.

    Google Scholar 

  34. Saini SS, MacGlashan Jr DW, Sterbinsky SA, et al. Down-regulation of human basophil IgE FC epsilon RI alpha surface densities and mediator release by anti-IgE infusions is reversible in vitro and in vivo. U Immunol. 1999;162:5624–30.

    CAS  Google Scholar 

  35. Prussin C, Griffith DE, Boesel KM, Lin H, Foster B, Casale TB. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol. 2003;112:1147–54.

    Article  PubMed  CAS  Google Scholar 

  36. Borkowski TA, Jouvin MH, Lin SY, Kinet JP. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol. 2001;167:1290–6.

    PubMed  CAS  Google Scholar 

  37. Kiijmoto-Ochiai S. CD23 (the low affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule. Cell Mol Life Sci. 2002;59:648–64.

    Article  Google Scholar 

  38. Bonnefoy JY, Plater-Zyberk C, Leoanet-Henchoz S, et al. A new role for CD23 in inflammation. Immunol Today. 1996;17:418–20.

    Article  PubMed  CAS  Google Scholar 

  39. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY. CD21 is a ligand for CD23 and regulates IgE production. Nature. 1992;358:505–7.

    Article  PubMed  CAS  Google Scholar 

  40. Herbelin A, Elhadad S, Ouaac F, de Groote D, Descamps-Latscha B. Soluble C23 potentiates interleukin-1 secretion of interleukin 6 and interleukin-1 receptor antagonist by human monocytes. Eur J Immunol. 1994;24:1869–73.

    Article  PubMed  CAS  Google Scholar 

  41. Henchoz S, Gauchat JF, Aubry JP, et al. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of co-signal to modulate epsilon transcripts. Immunology. 1994;81:285–90.

    PubMed  CAS  Google Scholar 

  42. Liu UJ, Kanzler H, Somelia V, Gillet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585–9.

    Article  PubMed  CAS  Google Scholar 

  43. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183–6.

    Article  PubMed  CAS  Google Scholar 

  44. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today. 1999;20:561–7.

    Article  PubMed  CAS  Google Scholar 

  45. Feuchtinger T, Bartz H, von Berg A, et al. Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season. J Allergy Clin Immunol. 2003;111:428–30.

    PubMed  Google Scholar 

  46. Presta LG, Lahr SJ, Shields RI, et al. Humanization of an antibody directed against IgE. J Immunol. 1993;151:2623–32.

    PubMed  CAS  Google Scholar 

  47. Shields RL, Whether WR, Zioncheck K, et al. Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol. 1995;107:308–12.

    Article  PubMed  CAS  Google Scholar 

  48. Fox JA, Hotaling TE, Struble C, Ruppel J, Bates DJ, Schoenhoff MB. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys. J Pharmacol Exp Ther. 1996;279:1000–8.

    PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr. Rosenwasser has served as a consultant for Regeneron Pharmaceuticals and Sanofi-Aventis and has received grant support from Novartis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lanny J. Rosenwasser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenwasser, L.J. Mechanisms of IgE Inflammation. Curr Allergy Asthma Rep 11, 178–183 (2011). https://doi.org/10.1007/s11882-011-0179-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-011-0179-6

Keywords

Navigation